A multipart phase 1 study of the safety, pharmacodynamics and pharmacokinetics of ALG-055009, a novel thyroid hormone receptor beta (THR-β) agonist for metabolic dysfunction-associated steatohepatitis (MASH), in healthy participants.

ALG-055009 - Aligos Therap

http://www.ncbi.nlm.nih.gov/pubmed/40971152

Benedetta Massetto; Hakim Charfi; Ifong Kan-Eng; John Fry; Kha Le; Lawrence Blatt; Meenakshi Venkatraman; Megan Fitzgerald; Naqvi Mohammad; Stanley Wang; Sushmita M Chanda; Tse-I Lin

Sep 19, 2025